* . *

The Washington Post

FDA approves a novel drug for schizophrenia, a potential ‘game changer’

The Washington Post on September 28, 2024

The approval comes less than a year Bristol Myers Squibb paid $14 billion to acquire the developer of the drug, Karuna Therapeutics.

Source link : https://www.washingtonpost.com/business/2024/09/26/fda-antipsychotic-mental-illness-alzheimers/

Author : Daniel Gilbert

Publish date : 2024-09-26 23:10:36

Copyright for syndicated content belongs to the linked Source.

Tags : The Washington Post

.. . . . . . . . . . . . . . . . . . . . . . . . . %%%. . . * . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ - - - - - - - - - - - - - - - - - - - - . . . . .